Kowa Pharmaceutical Europe Co. Ltd.

Innovation through collaboration

Kowa Pharmaceutical Europe Co. Ltd. is a specialty pharmaceutical company located in the UK and is a division of Kowa Company, Ltd., a multinational Japanese company actively engaged in a broad variety of manufacturing and trading activities.  Kowa are committed to improving health standards in Europe and globally.

Our treatment areas

We proudly supply a wide range of products from prescription medicines to
retinal cameras and other medical diagnostic products.

Lifestyle-related
diseases
  • Dyslipidemia
  • Type 2 Diabetes
  • Arteriosclerotic disease
Immunity
inflammation
  • Cancer
  • Inflammatory disease
  • Skin disease
Sensory organ
diseases
  • Eye disease
  • Equilibrium and auditory function disorders
Diagnostic
devices
  • Non-Mydriatic Retinal Cameras
  • Combination Retinal Cameras
  • Portable Retinal Cameras
  • Software
  • Refraction
  • Diagnostic
  • Anterior

Kowa is committed to the global healthcare community.

¥422,576m

Sales

Fiscal year March 31 2020
Kowa Group Consolidated

6,583

Employees

 March 2020 Kowa Group
Consolidated

44

Major subsidiaries

Affiliates in Japan, Asia, North America,
Latin America, and Europe

Report adverse event

Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.

Patients and Volunteers in clinical trials reporting an adverse event must contact the investigator.

For specific medical information requests please visit the relevant product page to get in touch.

For the reporting of Livazo adverse events within Europe Union please contact local distributor or Recordati

For the reporting of Livazo adverse events within Middle East and North Africa (MENA) please contact...

Contact us












    I confirm I have read and accept the terms of the Privacy policy